Scientific Discussions
Collectively driving advancements in the field of Oncology, we participate in scientific discussions and events to contribute our best to enhance knowledge base and effectively contribute to advancements in cancer treatments. Every scientific discourse participated by OneCell Diagnostics team is an opportunity to share knowledge and experience and effectively better therapeutic interventions.
Mohan Uttarwar
AI to Democratize the Adaptation of Precision Oncology: Augmented Intelligence for Oncologists
At the 3rd Indian Cancer Congress 2023
Dr Gowhar Shafi
Artificial Intelligence Redefining Patient’s Eligibility for Immunotherapy
At the 3rd Indian Cancer Congress 2023
Scientific Session
Dr Gowhar Shafi What is Comprehensive Genomic Profiling and How OncoIndx is different from other CGP tests available in the market?
Dr. Kumar Prabhash Advancing Comprehensive Liquid Biopsies in Non-Small Cell Lung Cancer: Insights from Indian Patient Data
Dr. T. Raja From Bench to Bedside: Liquid Biopsy Real-World Evidence in Oncology (Panel Discussion)
At the 3rd Indian Cancer Congress 2023
TEDx Talk
Aravindan Vasudevan
Date: Feb 28, 2023
Describing cancer cell as the ‘Perfect Villain’ and focusing on how we could help eradicate its conception altogether, Aravindan talks about how they have successfully been able to research and develop various ways to detect early, decode cancer diversity with precision medicine, mimic the tumor microenvironment and liquid biopsy that helps find markers of cancer that has travelled through the bloodstream. Aravindan Vasudevan is the co-founder of Actorius Innovations and Research and OneCell Diagnostics. At Actorius, Aravindan was part of the team which developed the OncoDiscover – Circulating Tumor Cell Technology, India’s first indigenously developed DCGi approved IVD technology. He also leads the operations of OneCell Diagnostics which is a precision oncology company focussed on developing multi-omics technologies for cancer therapy and drug discovery. This talk was given at a TEDx event using the TED conference format but independently organized by a local community.
Learn more at https://www.ted.com/tedx
Mohan Uttarwar
Emerging role of technology in precision medicine.
Introducing iCore platform, that marries the power of cutting edge technology with precision oncology for advancing cancer care through the incredible science of AI/ML and data analytics.
Dr Jayant Khandare
Functional Assays to Detect EGFR, PD-L1 & HER 2 on CTCs
Watch the full conference at https://www.youtube.com/watch?v=wZTR73E5OzQ
Dr Pankaj Chaturvedi
On organising Scientific Conference by OneCell
on the World Head & Neck Cancer Day 2022
Cancer is in Circulation.
Circulating Tumor Cells
Circulating Tumor Cells are cells that are shed into the bloodstream by the primary tumor. CTCs have been investigated as diagnostic, prognostic and predictive biomarkers in many types of cancer.
CTC serve as seeds for growth of additional tumors (metastasis) in vital distant organs.
CTC counts are associated with unfavorable prognosis in early stage cancer patients.
CTC Clusters
CTC clusters are defined as groups of two or more aggregated CTCs found in the blood of patients with solid tumor.
CTC cluster have a survival advantage over individual CTC during their transit in the blood stream and an aggressive potential for colonization in the distant sites and can likely contribute to metastasis.
Cell and Cellular Division
The Cell is the basic building block of the human body and there are trillions of cells. Cells have the unique characteristic of replicating (or replicating themselves) via cell division and propagating to perform other critical functions for human survival. The cells also have a function which tells them when to stop dividing and undergo a process called Apoptosis (programmed cell death). This way the body clears the old cells and new cells every day.
Tumor and Angiogenesis
Due to various factors such as pollution, poor diet, smoking, radiation etc, some normal cells undergo mutation in a process known as carcinogenesis to become cancer cells. These cancer cells grow abnormally and indefinitely, subsequently congregating form a mass known as Tumor. These tumors survive by creating new blood vessels (for oxygen and nutrient supply) in a process known as Angiogenesis.
Cancer Metastasis.
The tumor is a mass of cancer cells from which some cells try to move away and invade the body via the circulatory system. These cells enter and circulate in the blood stream via a process known as Intravasation. These cells are known as Circulating Tumor Cells (CTC). Circulating Tumor Cells (CTC) have the ability to also get out of the blood stream via Extravasation. Thus, cancers cells can travel from one tissue/organ to another and potentially form a new tumor in the invaded tissue/organ. This process is known as metastasis and it is responsible for 90% of cancer related deaths worldwide.
Circulating Tumor Cells (CTC)
Each gram of tumor tissue sheds upto 1 million cancer cells into the blood stream each day. These Circulating Tumor Cells (CTC) serve as seeds for growth of additional tumors (metastasis) in vital distal organs. There is a positive correlation between CTC number and the clinical status of the cancer. OncoDiscover® CTC Test allows for regular monitoring of disease progression and can serve as an early indicator for relapse.
Our team of world-class scientists and clinicians are committed to advancing the field of precision oncology, developing new and innovative solutions to improve cancer care.
